Want $500 in Super Safe Annual Dividend Income? Invest $9,900 in the Following 3 Dividend KingsThe Motley Fool • 07/30/23
Compared to Estimates, AbbVie (ABBV) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 07/27/23
Top JP Morgan Strategist Says the Worst May Still Be Coming: 7 Big-Dividend Blue Chips to Buy Now24/7 Wall Street • 07/27/23
AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical AssetsPRNewsWire • 07/26/23
SKYRIZI® (risankizumab) Achieved Superiority Versus Apremilast for Co-Primary Endpoints Among Adult Patients with Moderate Plaque Psoriasis in Phase 4 Head-to-Head StudyPRNewsWire • 07/26/23
AbbVie turns to newer immunology drugs as blockbuster Humira faces lower-cost competitionMarket Watch • 07/25/23